![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 04, 2009 7:20:55 PM
Sent: Wednesday, November 04, 2009 3:29 PM
To: Vivian Huyen
Subject: RE: Update on company activies
Ms. Huyen,
Thank you for your kind comments and your interest in Paradigm Medical. The recent meeting in San Francisco was very productive and will serve as a solid spring-board for introducing two of our highlighted products, Paravue 300 and Surveyor 500. These two corneal topographers are what we feel are some of the very best available. We will begin formal training and roll out shortly following the move to our new location. We are anxiously awaiting FDA approval for our new ParaMax for sale in the US market and worldwide. We are hopeful for an FDA approval during the fourth quarter this year. Tough time never last, but tough people and organizations do!
sld
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM